Company / Debt per Share
Idexx Laboratories Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$5.51
FY2025
5-year range
$5.51 / $9.96
FY2021-FY2025
Trend
-25.9%
vs FY2024
Sector context
#70 of 100
Health Care
What the data says
At $5.51, Idexx Laboratories's debt per share ranks #31 of 100 in the Health Care sector. Debt per Share has declined for 5 consecutive years, from $10.64 in FY2020 to $5.51 in FY2025.
Based on SEC 10-K filings.
5.51 in FY2025 with a 5-year CAGR of -12.3%.
Improved from $8.42 to $5.51 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -15.4%
- 5-Year CAGR
- -12.3%
- 10-Year CAGR
- -
Sector benchmark
#31 of 100 in Health CareTop 30% of 100This company $5.51 Sector average $45.71
▼
-87.9% below sector average
Key checks
Key Insights
- Idexx Laboratories's debt per share has declined for 5 consecutive years.
- In FY2025, debt per share decreased 25.9% year-over-year.
- Ranks #70 out of 100 companies in the Health Care sector.
- Peak debt per share was recorded in FY2020.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.51 | -25.9% |
| FY2024 | $7.44 | -11.7% |
| FY2023 | $8.42 | -7.5% |
| FY2022 | $9.10 | -8.6% |
| FY2021 | $9.96 | -6.4% |
| FY2020 | $10.64 | +30.9% |
| FY2019 | $8.12 | +17.6% |
| FY2018 | $6.91 | +6.7% |
| FY2017 | $6.48 | +10.7% |
| FY2016 | $5.85 | +5.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026